Real-World Outcomes In Patients With Chronic Hepatitis C Virus Infection And Substance Abuse Disorders Treated With Glecaprevir/Pibrentasvir For 8 Weeks: A Pooled Analysis Of Multinational Post-Marketing Observational Studies
                        AuthID
P-00S-ZQP
                
    P-00S-ZQP
 
    
                    